Blogs & Articles

Revvity Signals 2024: Empowering Scientific Innovation and Collaboration

In 2024, Signals ChemDraw, Signals Clinical and Signals Synergy launched. Read how Revvity Signals supports new modalities in drug discovery and research development.

January 7, 2025 Read Blog

WRITTEN BY:

Mary Donlan, Ph.D.

Executive Director, Product Marketing

Featured Blogs

December 10, 2024 Rick Percuoco

From Data Overload to Insight: Using AI and ML for Security Trend Prediction

Artificial intelligence (AI) and machine learning (ML) are revolutionizing the cybersecurity space. Learn how Revvity Signals uses AI and other techniques to protect data.

November 12, 2024 Zev Wisotsky, Ph.D.

The Evolving Landscape of PROTAC® Technology: Implications for Small Molecule and Multimodal Drug Discovery

PROTAC technology and TPD research present many opportunities in drug discovery. Learn how Signals Research Suite provides a comprehensive R&D workflow.

digital transformation 10-29-2024 Blog Header.png

October 29, 2024 Jun Liu

Unlocking Insights Through Data: Digital Transformation in Formulation Science

AI-Powered Drug Discovery Possibilities | Revvity Signals Software

September 17, 2024 Zev Wisotsky, Ph.D.

The Impact of Software Platforms on CRO and Biopharma Partnerships | Revvity Signals Software

September 3, 2024 Chris Stumpf

The Future of Chemical Drawing | Revvity Signals Software

August 20, 2024 Pierre Morieux, Ph.D.

Drug Discovery: Old realities meet with new modalities

August 6, 2024 Zev Wisotsky, Ph.D.

Enabling the next research breakthroughs with virtual CROs

July 23, 2024 Chris Stumpf

The State of Digital Transformation in the Specialty Chemicals Industry

July 8, 2024 Jun Liu

Security & Compliance: Why Data is Safer with Revvity Signals Software

June 25, 2024 Rick Percuoco

What the HELM?! How to Unlock Communications for New Modalities of Drug Development

June 10, 2024 Zev Wisotsky, Ph.D.

How to Power R&D Workflow Digital Transformation with Integration-Ready SaaS Applications

May 28, 2024 Diana Tran

Copy of BlogArticle Hero Template (1360 x 640 px) (3).webp

September 17, 2024 Zev Wisotsky, Ph.D.

AI-Powered Drug Discovery Possibilities | Revvity Signals Software

Revvity Signals helps take advantage of AI-ready data within antibody drug discovery. Learn how Signals Research Suite can help accelerate scientific.

September 3, 2024 Chris Stumpf

The Impact of Software Platforms on CRO and Biopharma Partnerships | Revvity Signals Software

Signals Synergy enhances collaboration and information between CROs and sponsors. Learn how Signals Synergy improves communication and project management with CROs.

Copy of BlogArticle Hero Template (1360 x 640 px).webp

August 20, 2024 Pierre Morieux, Ph.D.

The Future of Chemical Drawing | Revvity Signals Software

ChemDraw+ is not just an upgrade; it’s a game-changer, designed for today’s evolving needs of chemists. Learn what ChemDraw+ offers and how to request a free trial.